Search

Your search keyword '"Spruijt, Liesbeth"' showing total 224 results

Search Constraints

Start Over You searched for: Author "Spruijt, Liesbeth" Remove constraint Author: "Spruijt, Liesbeth"
224 results on '"Spruijt, Liesbeth"'

Search Results

1. The heterogeneous cancer phenotype of individuals with biallelic germline pathogenic variants in CHEK2

2. Genetic Cancer Susceptibility in Adolescents and Adults 25 Years or Younger With Colorectal Cancer

4. SNP association study in PMS2-associated Lynch syndrome

5. The effect of genotypes and parent of origin on cancer risk and age of cancer development in PMS2 mutation carriers

6. Allelic Mutations of KITLG, Encoding KIT Ligand, Cause Asymmetric and Unilateral Hearing Loss and Waardenburg Syndrome Type 2

10. Pathogenetics of alveolar capillary dysplasia with misalignment of pulmonary veins

11. Germline Mutations in the Spindle Assembly Checkpoint Genes BUB1 and BUB3 Are Risk Factors for Colorectal Cancer

12. Neurofibromas in LZTR1 schwannomatosis

16. Mutation and association analyses of the candidate genes ESR1, ESR2, MAX, PCNA, and KAT2A in patients with unexplained MSH2-deficient tumors

17. Exome sequencing identifies WDR35 variants involved in sensenbrenner syndrome

20. Clinical Expression of Leber Hereditary Optic Neuropathy Is Affected by the Mitochondrial DNA–Haplogroup Background

22. Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder

23. A Post-Hoc Comparison of the Utility of Sanger Sequencing and Exome Sequencing for the Diagnosis of Heterogeneous Diseases

25. C14ORF179 encoding IFT43 is mutated in Sensenbrenner syndrome

26. TINF2 is a haploinsufficient tumor suppressor that limits telomere length

27. Author response: TINF2 is a haploinsufficient tumor suppressor that limits telomere length

29. TINF2 is a haploinsufficient tumor suppressor that limits telomere length

33. DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct

34. Role of germline aberrations affecting,andin gastric cancer susceptibility

35. The Apparent Genetic Anticipation in PMS2-Associated Lynch Syndrome Families Is Explained by Birth-cohort Effect

36. Evaluation of yield and experiences of age‐related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome.

37. Cancer Risks for PMS2-Associated Lynch Syndrome

38. Cancer Risks for PMS2-associated lynch syndrom

39. SNP association study in PMS2-associated Lynch syndrome

40. Molecular Background of Colorectal Tumors From Patients With Lynch Syndrome Associated With Germline Variants in PMS2

41. Cancer Risks for PMS2-associated lynch syndrom

42. Clinical aspects of SDHA-related pheochromocytoma and paraganglioma: A nationwide study

43. Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility

44. CORRIGENDUM: The effect of genotypes and parent of origin on cancer risk and age of cancer development in PMS2 mutation carriers

45. Clinical Aspects of SDHA-Related Pheochromocytoma and Paraganglioma: A Nationwide Study

46. SNP association study in PMS2-associated Lynch syndrome

47. Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing

48. Pancreatic cancer-associated gene polymorphisms in a nation-wide cohort of p16-Leiden germline mutation carriers; A case-control study Medical Genetics

49. Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing

50. Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing

Catalog

Books, media, physical & digital resources